H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

SARS-CoV-2 infection regulates protein arginylation

A new study explores the role of arginylation during SARS-CoV-2 infection.

9 Nov 2021

SARS-CoV-2 infection in white-tailed deer

In the current study, SARS-CoV-2 antibodies were identified in over a third of free-ranging deer in northeast Ohio.

9 Nov 2021

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Researchers have tried to develop an innovative platform for ultrasensitive and rapid detection of SARS-CoV-2 by exploiting a variation of Raman Spectroscopy.

4 Nov 2021

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Researchers evaluate the safety and immunogenicity of an influenza vaccine and mRNA-based COVID-19 vaccine that were administered concomitantly.

3 Nov 2021

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.

3 Nov 2021

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

A new review discusses how molecular and structural biology have contributed to our understanding of antibody recognition of HIV-1, SARS-CoV-2, and Zika.

1 Nov 2021

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Researchers emphasize that an effective vaccine should induce mucosal immunity and prevent the nasal entry of SARS-CoV-2.

27 Oct 2021

Study explores cross-cultural differences in knowledge, attitude towards COVID-19

A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.

20 Oct 2021

Researchers launch new project for improving the ability to predict, respond to future pandemics

A multidisciplinary national research team led by University of Utah Health scientists has launched a comprehensive review and analysis of data collected about COVID-19 in hopes of improving the nation’s ability to predict, detect, and respond to future pandemics.

20 Oct 2021

How did the COVID-19 pandemic impact the circulation of other respiratory viruses in New York City?

Researchers from Columbia University have been investigating the impact of the pandemic on the spread of non-coronavirus respiratory viral infections in New York.

19 Oct 2021

New study shows how COVID-19 response has impacted the U.S. public health system

The cruel impact of COVID-19, the virus that emerged in late 2019 and has claimed 5 million lives to date, is chronicled in daily headlines. It has robbed us of loved ones, jobs, plans and so much more.

15 Oct 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

Scientists testify the importance of timely influenza vaccination

With flu season approaching in the United States, new research from an international team of scientists testifies to the importance of timely vaccination

15 Oct 2021

Poor timing of flu vaccinations associated with poor birth outcomes and cesarean births

With flu season approaching in the United States, new research from an international team of scientists testifies to the importance of timely vaccination: Poor timing of influenza vaccination campaigns in the semi-arid region of Brazil led to an increase in premature births, lower birth-weight babies and the need to deliver more babies by cesarean section, the researchers found.

13 Oct 2021

H1N1 News and Research

SARS-CoV-2 infection regulates protein arginylation

SARS-CoV-2 infection in white-tailed deer

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Study explores cross-cultural differences in knowledge, attitude towards COVID-19

Researchers launch new project for improving the ability to predict, respond to future pandemics

How did the COVID-19 pandemic impact the circulation of other respiratory viruses in New York City?

New study shows how COVID-19 response has impacted the U.S. public health system

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

Scientists testify the importance of timely influenza vaccination

Poor timing of flu vaccinations associated with poor birth outcomes and cesarean births

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

Failures and findings from randomized clinical trials in COVID-19 convalescent plasma

Flu shots and COVID-19 immunity

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

New online tool to help medical staff quickly support COVID-19 patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News